33 Queen Square, Institute of Neurology, UCL
London, WC1N 3BG, United Kingdom
NCT Number: NCT04634864
This is a double-blind, sham-controlled, anodal tDCS study to understand the effect of increasing motor cortex excitability on post-stroke fatigue.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
London, WC1N 3BG, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Diagnosed with stroke at least 3 months post-stroke
Exclusion criteria
Other neurological conditions on Anti-depressants severe motor impairment (affected hand grip <60% unaffected hand) severe cognitive impairment (unable to follow instructions, or give informed consent) scored >11 in the depression sub-section of HADS questionnaire contraindications for TMS or tES
40 minutes of 2mA intensity direct current stimulation was delivered over both the right and left motor cortex simultaneously
The stimulator was switched off after 2 minutes of stimulation.
Time frame: 2 weeks
a questionnaire based fatigue scale
Time frame: 1 day
This is a measure of cortical excitability as measured by transcranial magnetic stimulation
Time frame: 1 day
This is a measure of cortical recruitment as measured by transcranial magnetic stimulation
Time frame: 1 day
A VAS scale associated with a grip task
Time frame: 1 day
A novel line length estimation task
University College, London
Other
tDCS in Post-stroke Fatigue: a Double Blind, Sham-controlled, Bilateral Anodal Motor Cortical Stimulation Study
Acronym: TIPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06513377
Atrophy, Brain Diseases
Jette, Brussels Capital, Belgium
View Trial DetailsNCT05330988
Brain Diseases, Cardiovascular Diseases
Charleston, South Carolina, United States
View Trial DetailsNCT06296225
Brain Diseases, Cardiovascular Diseases
Chartres, France
View Trial DetailsNCT04866420
Brain Diseases, Cardiovascular Diseases
Oxford, Oxfordshire, United Kingdom
View Trial Details